Fig. 1: Pretreatment easTILs% and pathologist-read sTILs% by pCR and treatment status. | npj Breast Cancer

Fig. 1: Pretreatment easTILs% and pathologist-read sTILs% by pCR and treatment status.

From: Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

Fig. 1

a Pretreatment easTILs% by pCR status. b Pathologist-read sTILs% by pCR status. c Pretreatment easTILs% by pCR and treatment status. d Pretreatment sTILs% by pCR and treatment status. TILs tumor-infiltrating lymphocytes, easTILs% = [sum of lymphocytes area/stromal area] × 100, sTILs% pathologist assessment of stromal TILs, RD residual disease, pCR pathologic complete response, C control, chemotherapy alone, B bevacizumab + chemotherapy. Box and whiskers plots are shown with min to max whiskers that go down to the smallest value and up to the largest. Statistical analysis was performed using Mann–Whitney test.

Back to article page